Chris Lange.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
Top Performing Calls
Coverage
Background
| BA Business | 2011 |
| BBVA · Associate | 2013-2014 |
| TBLA · Director of Operations | 2012-2013 |
Essential Reading
How I Think About Money
- 01 Asset owners will always outpace wage earners, so invest wisely.
- 02 Compound interest is the most powerful force in the world.
Recent Work
14,004 articlesAMGN vs. MRK: Which Pharma Giant’s Dividend Actually Has Room to Grow
Amgen and Merck both yield around 2.3% and have surged this year, but one of them is paying its dividend out of thin air while the other has a cash cushion that…
A $600,000 Dividend Portfolio Has a $52,900 Tax Problem. Here’s the Roth Solution
Six popular dividend stocks sitting in a taxable account quietly hand a portion of every payout to the IRS, and the gap between what you earn and what you keep widens sharply…
3 Overlooked Healthcare Dividend Stocks That Could Keep Paying for Decades
Most income investors chase flashy yields and overlook the quiet compounders that have raised their dividends through recessions, rate shocks, and global pandemics. Three healthcare stocks prove that the most reliable paycheck…